vs

Side-by-side financial comparison of Hyperscale Data, Inc. (GPUS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $26.9M, roughly 1.4× Hyperscale Data, Inc.). On growth, Hyperscale Data, Inc. posted the faster year-over-year revenue change (38.4% vs -57.1%). Over the past eight quarters, Hyperscale Data, Inc.'s revenue compounded faster (-16.3% CAGR vs -46.5%).

Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GPUS vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$37.2M
$26.9M
GPUS
Growing faster (revenue YoY)
GPUS
GPUS
+95.4% gap
GPUS
38.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
GPUS
GPUS
Annualised
GPUS
-16.3%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GPUS
GPUS
ORGO
ORGO
Revenue
$26.9M
$37.2M
Net Profit
$-30.1M
Gross Margin
14.5%
30.8%
Operating Margin
-117.8%
-185.1%
Net Margin
-112.0%
Revenue YoY
38.4%
-57.1%
Net Profit YoY
-6670.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPUS
GPUS
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$26.9M
$225.6M
Q3 25
$24.3M
$150.9M
Q2 25
$25.9M
$101.0M
Q1 25
$25.0M
$86.7M
Q4 24
$19.4M
$126.7M
Q3 24
$31.1M
$115.2M
Q2 24
$17.8M
$130.2M
Net Profit
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$-30.1M
$43.7M
Q3 25
$-13.0M
$21.6M
Q2 25
$-19.1M
$-9.4M
Q1 25
$-4.2M
$-18.8M
Q4 24
$-445.0K
$7.7M
Q3 24
$-25.5M
$12.3M
Q2 24
$-33.9M
$-17.0M
Gross Margin
GPUS
GPUS
ORGO
ORGO
Q1 26
30.8%
Q4 25
14.5%
Q3 25
25.8%
Q2 25
23.7%
Q1 25
21.1%
72.6%
Q4 24
6.5%
75.5%
Q3 24
27.5%
76.7%
Q2 24
-21.3%
77.6%
Operating Margin
GPUS
GPUS
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-117.8%
28.1%
Q3 25
-57.8%
13.7%
Q2 25
-39.2%
-12.5%
Q1 25
-25.5%
-30.9%
Q4 24
-46.8%
8.1%
Q3 24
-79.2%
5.4%
Q2 24
-151.4%
-10.7%
Net Margin
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
-112.0%
19.4%
Q3 25
-53.5%
14.3%
Q2 25
-73.7%
-9.3%
Q1 25
-16.8%
-21.7%
Q4 24
-2.3%
6.1%
Q3 24
-82.3%
10.7%
Q2 24
-190.7%
-13.1%
EPS (diluted)
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$-0.39
$0.11
Q2 25
$-2.66
$-0.10
Q1 25
$-0.17
Q4 24
$-8.78
$0.05
Q3 24
$-24.82
$0.09
Q2 24
$-37.81
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPUS
GPUS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$13.1M
$91.4M
Total DebtLower is stronger
$83.1M
Stockholders' EquityBook value
$119.8M
Total Assets
$313.7M
$520.0M
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPUS
GPUS
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$13.1M
$93.7M
Q3 25
$24.8M
$63.7M
Q2 25
$5.9M
$73.1M
Q1 25
$4.2M
$110.0M
Q4 24
$4.5M
$135.6M
Q3 24
$7.9M
$94.3M
Q2 24
$9.6M
$89.9M
Total Debt
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$83.1M
Q3 25
$80.0M
Q2 25
$88.5M
Q1 25
$92.8M
Q4 24
$96.7M
Q3 24
$104.8M
$62.3M
Q2 24
$106.8M
$63.8M
Stockholders' Equity
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$119.8M
$300.1M
Q3 25
$55.9M
$255.1M
Q2 25
$5.5M
$233.2M
Q1 25
$6.3M
$242.9M
Q4 24
$8.6M
$262.9M
Q3 24
$2.7M
$278.5M
Q2 24
$26.7M
$263.5M
Total Assets
GPUS
GPUS
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$313.7M
$598.7M
Q3 25
$242.4M
$509.8M
Q2 25
$213.5M
$461.1M
Q1 25
$218.5M
$467.4M
Q4 24
$220.8M
$497.9M
Q3 24
$231.5M
$446.3M
Q2 24
$270.8M
$443.2M
Debt / Equity
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
0.69×
Q3 25
1.43×
Q2 25
16.06×
Q1 25
14.71×
Q4 24
11.19×
Q3 24
38.41×
0.22×
Q2 24
4.00×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPUS
GPUS
ORGO
ORGO
Operating Cash FlowLast quarter
$-37.7M
Free Cash FlowOCF − Capex
$-56.2M
FCF MarginFCF / Revenue
-208.7%
Capex IntensityCapex / Revenue
68.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-87.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$-37.7M
$39.4M
Q3 25
$-17.8M
$3.1M
Q2 25
$-3.1M
$-32.9M
Q1 25
$-4.0M
$-19.9M
Q4 24
$-9.2M
$10.9M
Q3 24
$3.7M
$8.7M
Q2 24
$-3.7M
$4.7M
Free Cash Flow
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
$-56.2M
$34.8M
Q3 25
$-20.6M
$844.0K
Q2 25
$-3.5M
$-36.5M
Q1 25
$-6.8M
$-23.6M
Q4 24
$-9.3M
$7.6M
Q3 24
$2.6M
$6.1M
Q2 24
$-5.9M
$2.9M
FCF Margin
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
-208.7%
15.4%
Q3 25
-84.5%
0.6%
Q2 25
-13.5%
-36.1%
Q1 25
-27.3%
-27.2%
Q4 24
-47.6%
6.0%
Q3 24
8.4%
5.3%
Q2 24
-33.4%
2.2%
Capex Intensity
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
68.6%
2.1%
Q3 25
11.5%
1.5%
Q2 25
1.5%
3.6%
Q1 25
11.5%
4.2%
Q4 24
0.3%
2.7%
Q3 24
3.6%
2.2%
Q2 24
12.6%
1.4%
Cash Conversion
GPUS
GPUS
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPUS
GPUS

Transferred Over Time$10.4M39%
Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities$5.8M21%
Hotel And Real Estate Operations$4.8M18%
Other$4.0M15%
Turn On Green$2.0M7%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons